Kynos Therapeutics Ltd
- Company number
- 12501037
- Status
- Liquidation
- Type
- Private Limited Company
- Incorporated
- 5 Mar 2020
- Nature of business
- Research and experimental development on biotechnology
Registered office
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Professor Scott Peter Webster | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
5 Mar 2020 | 3 Feb 2022 |
| Professor Damian James Mole | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
5 Mar 2020 | 3 Feb 2022 |
| Dr. Martin Falk | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
28 Oct 2024 |
Accounts
| Year ended | Net assets | Employees |
|---|---|---|
| 31 Dec 2023 | - | - |
| 31 Dec 2022 | - | - |
| 31 Dec 2021 | -£21,006 | 0 |
| 31 Mar 2021 | £2,240 | 2 |
Connections
Companies at the same address
- DR. Falk Pharma UK Limited (02307698)